📣 VC round data is live. Check it out!
- Public Comps
- APT Medical
APT Medical Valuation Multiples
Discover revenue and EBITDA valuation multiples for APT Medical and similar public comparables like BillionToOne, Mirion, Imeik Technology Development, Cochlear and more.
APT Medical Overview
About APT Medical
APT Medical Inc is engaged in the research and development, production and sales of electrophysiological and vascular interventional medical devices for cardiovascular and cerebrovascular diseases. Its products are sold in Europe, Eastern Europe, Southeast Asia and other countries and other regions.
Founded
2002
HQ

Employees
N/A
Website
Financials (LTM)
EV
$4B
Valuation Multiples
Start free trialAPT Medical Financials
APT Medical reported last 12-month revenue of $419M and EBITDA of $167M.
In the same LTM period, APT Medical generated $306M in gross profit, $167M in EBITDA, and $133M in net income.
Revenue (LTM)
APT Medical P&L
In the most recent fiscal year, APT Medical reported revenue of $382M and EBITDA of $155M.
APT Medical is profitable as of last fiscal year, with gross margin of 73%, EBITDA margin of 41%, and net margin of 32%.
Financial data powered by Morningstar, Inc.
APT Medical Stock Performance
APT Medical has current market cap of $4B, and enterprise value of $4B.
Market Cap Evolution
APT Medical's stock price is $30.85.
APT Medical share price increased by 1.7% in the last 30 days, and decreased by 28.5% in the last year.
APT Medical has an EPS (earnings per share) of $0.86.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $4B | $4B | 2.0% | 1.7% | -15.9% | -28.5% | $0.86 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAPT Medical Valuation Multiples
APT Medical trades at 9.9x EV/Revenue multiple, and 25.0x EV/EBITDA.
EV / Revenue (LTM)
APT Medical Financial Valuation Multiples
As of June 4, 2026, APT Medical has market cap of $4B and EV of $4B.
APT Medical has a P/E ratio of 32.7x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified APT Medical Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


APT Medical Margins & Growth Rates
APT Medical grew revenue by 26% and EBITDA by 23% in the last fiscal year.
In the most recent fiscal year, APT Medical reported gross margin of 73%, EBITDA margin of 41%, and net margin of 32%.
APT Medical Margins
APT Medical Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
APT Medical Operational KPIs
APT Medical's Rule of 40 is 65% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
APT Medical's Rule of X is 104% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
APT Medical Competitors
APT Medical competitors include BillionToOne, Mirion, Imeik Technology Development, Cochlear, Rigaku, Caris Life Sciences, LivaNova, Jiangsu Yuyue Medical, Canon Marketing Japan and Ottobock.
Most APT Medical public comparables operate across Medical Devices, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 12.9x | 10.7x | 105.5x | 67.9x | |||
| 5.7x | 5.2x | 23.0x | 20.6x | |||
| 11.0x | 10.6x | 17.1x | 17.8x | |||
| 2.7x | 2.7x | 10.3x | 13.0x | |||
| 7.9x | 7.7x | 34.1x | 32.2x | |||
| 5.3x | 4.8x | 31.0x | 29.5x | |||
| 2.8x | 2.7x | 12.1x | 11.6x | |||
| 3.3x | 3.2x | 13.3x | 16.2x | |||
This data is available for Pro users. Sign up to see all APT Medical competitors and their valuation data. Start Free Trial | ||||||
APT Medical VC Funding History
Before going public, APT Medical raised $61M in total equity funding, across 4 rounds.
Last private valuation of APT Medical was $87M, after raising $4M in October 2016 from Qiming Venture Partners.
APT Medical Funding Rounds
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout APT Medical
| When was APT Medical founded? | APT Medical was founded in 2002. |
| Where is APT Medical headquartered? | APT Medical is headquartered in China. |
| Is APT Medical publicly listed? | Yes, APT Medical is a public company listed on Shanghai Stock Exchange. |
| What is the stock symbol of APT Medical? | APT Medical trades under 688617 ticker. |
| When did APT Medical go public? | APT Medical went public in 2021. |
| Who are competitors of APT Medical? | APT Medical main competitors include BillionToOne, Mirion, Imeik Technology Development, Cochlear, Rigaku, Caris Life Sciences, LivaNova, Jiangsu Yuyue Medical, Canon Marketing Japan, Ottobock. |
| What is the current market cap of APT Medical? | APT Medical's current market cap is $4B. |
| What is the current revenue of APT Medical? | APT Medical's last 12 months revenue is $419M. |
| What is the current revenue growth of APT Medical? | APT Medical revenue growth (NTM/LTM) is 27%. |
| What is the current EV/Revenue multiple of APT Medical? | Current revenue multiple of APT Medical is 9.9x. |
| What is the current EBITDA of APT Medical? | APT Medical's last 12 months EBITDA is $167M. |
| What is APT Medical's EBITDA margin? | APT Medical's last 12 months EBITDA margin is 40%. |
| What is the current EV/EBITDA multiple of APT Medical? | Current EBITDA multiple of APT Medical is 25.0x. |
| What is the current FCF of APT Medical? | APT Medical's last 12 months FCF is $95M. |
| What is APT Medical's FCF margin? | APT Medical's last 12 months FCF margin is 23%. |
| What is the current EV/FCF multiple of APT Medical? | Current FCF multiple of APT Medical is 43.8x. |
| How many companies APT Medical has acquired to date? | APT Medical hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies APT Medical has invested to date? | APT Medical hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to APT Medical
Lists including APT Medical
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.